Process for the preparation and control of oral drug films
EP2594261A1
Composition for transdermal administration of rivastigmine
EP2594257A1
Orodispersible films for the manufacturing of individualised medicine or for large scale production
EP2486913A1
Rapidly disintegrating oral film formulation for Olanzapin
EP2374448A1
Oral film formulation
EP2298277A1
Transdermal patch formulation
EP2213278A1
Pharmaceutical preparation with improved stability of the active agent
WO2009043588A2
Ph regulating antibacterial films for the oral or vaginal cavity
EP2083794A2
Adhesive label with bittering agent and fluidifying agents for natural airway secretions
EP2076251A2
Non-mucoadhesive film dosage forms
EP2023907A1
Transdermal delivery system comprising sufentanil and its analogues
DE102006019293A1
Transdermal therapeutic system, useful for pain treatment, comprises a carrier layer, an adhesive layer comprising a pressure sensitive copolymer with a content of fentanyl and analogs and a removable protection layer
DE102006001162A1
Patch cover for atopic dermatitis
DE102005050654A1
lip paving
EP1784170A2
Atrium patch
DE102005003387A1
Plaster for administering active agents through body orifices, comprises adhesive and backing layers, both made of nonionic and anionic hydrocolloids in reverse ratios
DE102004056576A1
Rapid Card
MXPA04011759A
Plaster containing fentanyl.
DE10223835A1
Transdermal therapeutic system for delivery of fentanyl, to treat severe and/or chronic pain, including drug-containing adhesive matrix of specific basic acrylate copolymer requiring no penetration accelerators
